Status:
COMPLETED
Diffuse Diabetic Maculopathy With Intravitreal Triamcinolone or Laser
Lead Sponsor:
Hospital de Clinicas de Porto Alegre
Conditions:
Macular Edema
Eligibility:
All Genders
30+ years
Phase:
NA
Brief Summary
This study compares the use of intravitreous triamcinolone and laser therapy to treat maculopahty in patients with type 2 diabetes mellitus in a short-tem period of 6 months
Detailed Description
The purpose of this double blind randomized clinical trial was to compare the treatment of diffuse diabetic macular oedema with intravitreal triamcinolone and laser in patients with type 2 diabetes me...
Eligibility Criteria
Inclusion
- patients with type 2 DM, diffuse macular oedema secondary to diabetic retinopathy, seen at the Centre of Reference for Diabetic Retinopathy at Hospital de Clinicas de Porto Alegre (HCPA) and at the Ophthalmology Outpatient Clinic at HCPA,
Exclusion
- patients with type 2 DM and previous treatment of diffuse macular oedema secondary to diabetic retinopathy
Key Trial Info
Start Date :
September 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2006
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT00668239
Start Date
September 1 2004
End Date
June 1 2006
Last Update
April 29 2008
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital de Clínicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil, 90035-003
2
HOspital de Clínicas de Porto alegre
Porto Alegre, Rio Grande do Sul, Brazil, 9035/903
3
Hospital de Clínicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil, 90630040